Appeals court upholds Gore win over St. Jude Medical
June 9, 2014 by Brad Perriello
Appeals court upholds Gore win over St. Jude Medical
A federal appeals court today upheld a win for W.L. Gore & Assoc. in a patent war with St. Jude Medical (NYSE:STJ) over heart defect repair technology.
W.L. Gore claims win in patent war with St. Jude Medical
W.L. Gore & Assoc. claimed a win in its patent war with St. Jude Medical (NYSE:STJ) over heart defect repair technology, after a federal judge in Minnesota dismissed the suit.
Occlutech claims win in Dutch legal war with St. Jude Medical | Legal News
Occlutech GmbH is claiming victory in a legal battle with St. Jude Medical (NYSE:STJ) over structural heart implants, saying Holland’s Supreme Court upheld an earlier ruling in Occlutech’s favor.
St. Jude to expand in Plymouth, consolidating cardiovascular unit
St. Jude Medical Inc. (NYSE:STJ) plans to more than double its Plymouth, Minn. presence with a 3 floor, 275,000 square foot addition to its 5050 Nathan lane building.
Along with the build, the medical device giant plans to consolidate its cardiovascular unit to the new Plymouth campus. The company’s cardiovascular division currently leases locations in Minnetonka, Minn. and Maple Grove, Minn.
Occlutech claims German victory in latest patent fight round with St. Jude and AGA
Occlutech GmbH won another round in its ongoing patent dispute with St. Jude Medical Inc. (NYSE:STJ) acquisition AGA Medical.
The German Supreme Court (BGH) in Karlsruhe ruled that it does not see any basis for AGA Medical’s claim that Occlutech’s atrial septal defects (ASD) and patent foramen ovale (PFO) occlusion devices violate the company’s patents.
St. Jude Medical rises on Q1 results, Trifecta valve approval
St. Jude Medical Inc. (NYSE:STJ) shares rose today on news of its first-quarter sales and earnings and of FDA approval of its aortic valve replacement system, the Trifecta.
STJ shares were up 2.7 percent to $52.37 as of about 10:40 this morning, after the St. Paul, Minn.-based medical device maker reported profits of $233.4 million, or 71 cents per diluted share, on sales of $1.38 billion for the three months ended April 2 — a 9.0 percent top-line increase compared with Q1 2010.
St. Jude closes AGA Medical buyout
St. Jude Medical Inc. (NYSE:STJ) closed its $1.03 billion acquisition of rival cardiovascular device maker AGA Medical Holdings Inc. (NSDQ:AGAM) today.
The St. Paul, Minn.-based medical device developer said the acquisition gives it access to four new surgical markets, including the treatment of structural defects in the heart.
St. Jude concludes tender exchange in AGA Medical takeover
St. Jude Medical Inc. (NYSE:STJ) concluded its tender offer AGA Medical Holdings Inc. (NSDQ:AGAM) and expects to close its $1.03 billion acquisition of the rival cardiovascular device maker today.
The St. Paul, Minn.-based company said about 91.1 percent of AGA’s outstanding stock was tendered as part of its buyout of the company, and another 6.7 percent of AGA stock was tendered by notices of guaranteed delivery.
St. Jude sets share exchange rate for AGA Medical takeover
St. Jude Medical Inc. (NYSE:STJ) set the share exchange rate for its $1.3 billion half-cash, half-stock acquisition of AGA Medical Holdings Inc. (NSDQ:AGAM).
The St. Paul, Minn.-based medical device maker said it plans to provide AGA shareholders with 54 percent of a STJ share for every one AGAM share exchanged.
AGA Medical’s sale to St. Jude might be the fastest exit ever
When St. Jude Medical Inc. (NYSE:STJ) completes its $1.3 billion acquisition of AGA Medical Holdings Inc. (NSDQ:AGAM) at the end of the year, it just might be the quickest exit in Wall Street history.
